AstraZeneca agrees deal with Trump to lower drug prices for US patients - as NHS faces rocketing bill ⊕
found
a story from The Daily Mail 💩 › The Daily Mail
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
The British-Swedish company will now charge a 'Most Favored Nation' rate, matching the lowest price offered to other wealthy nations, to Medicaid.